Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

AVTXAVTX
3 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in AVALO THERAPEUTICS INC

GOLDMAN SACHS GROUP INC holds 946,320 shares of AVTX (AVALO THERAPEUTICS INC), worth $17.5M as of 2026-Q2. The position was increased (+1474.4% shares). AVTX represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$17.5M

Current Shares

946,320

Total Value Change

+$16.3M

Total Shares Change

+881,007

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
946,320
+1474.4%
$17.5M0.0%$18.48
46
2026-Q1
Decreased
60,106
-8.0%
$897,3830.0%$18.85
0
2025-Q4
New
65,313
-
$1.2M0.0%$17.81
35

Other major holders of AVTX: FMR LLC, BlackRock, Inc., STATE STREET CORP, FARALLON CAPITAL MANAGEMENT, L.L.C., Point72 Asset Management, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used